Market Overview

UPDATE: Morgan Stanley Cuts PT to $42 on MetLife Following Guidance

Share:
Related MET
Chubb Spikes On Ace Deal; This Expert Was Watching The Insurer 24 Hours Early
Deutsche Bank Names Top Life Insurance Buyout Target
Life Insurance Stock Prices And Higher Interest Rates (Seeking Alpha)

Morgan Stanley reiterated its Overweight rating on MetLife (NYSE: MET) but lowered its price target from $44 to $42.

Morgan Stanley noted, "MetLife's guidance was modestly disappointing, with both EPS and capital expectations running somewhat below our expectations. That said, their guidance is typically conservative (they typically hit at least the high end), and even with lowered numbers, the valuation multiple on stock is very low."

MetLife closed at $33.61 on Wednesday.

Latest Ratings for MET

DateFirmActionFromTo
Jun 2015RBC CapitalUpgradesSector PerformOutperform
May 2015Goldman SachsInitiates Coverage onNeutral
May 2015Deutsche BankMaintainsBuy

View More Analyst Ratings for MET
View the Latest Analyst Ratings

Posted-In: Morgan StanleyAnalyst Color Price Target Intraday Update Analyst Ratings

 

Related Articles (MET)

Around the Web, We're Loving...

Get Benzinga's Newsletters